Related Experiment Video
Updated: Jul 15, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study
Daniel Z Uslan1, Muhammad R Sohail, Jennifer L St Sauver
1Department of Medicine, Division of Infectious Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. duslan@mednet.ucla.edu
Insights
Cardiac device infections are common, particularly with Staphylococcus aureus bloodstream infections (BSI). Patients with defibrillators have a higher infection rate than those with pacemakers.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Cardiac device infection incidence is not well understood.
- Bloodstream infection (BSI) in patients with pacemakers or defibrillators may indicate device infection.
Purpose of the Study:
- To determine the incidence of cardiac device infection in a population-based cohort.
- To compare infection rates between pacemakers and defibrillators.
Main Methods:
- Retrospective, population-based cohort study (1975-2004) of adult cardiac device patients in Olmsted County, MN.
- Utilized the Rochester Epidemiology Project and standardized criteria to identify BSI and device infections.
- Calculated incidence using person-years of follow-up post-implantation.
Main Results:
- 1524 patients with cardiac devices were followed for 7578 person-years.
- The incidence of definite device infection was 1.9 per 1000 device-years.
- Device infection cumulative probability was higher for defibrillators than pacemakers (P<.001).
- Staphylococcus aureus BSI was associated with higher rates of definite or possible cardiac device infection (54.6%) compared to gram-negative bacilli BSI (12.0%).
Conclusions:
- This is the first population-based study to report cardiac device infection incidence.
- Cardiac device infection is common during Staphylococcus aureus BSI.
- Defibrillator recipients have a higher cardiac device infection rate than pacemaker recipients.
Background:
The incidence of cardiac device infection is not well understood. Bloodstream infection (BSI) in patients with permanent pacemakers or implantable cardioverter-defibrillators (hereafter, defibrillators) may reflect device infection.
Methods:
Retrospective, population-based cohort study of all adult patients with cardiac devices who resided in Olmsted County, Minnesota, from 1975 to 2004. The medical linkage-system of the Rochester Epidemiology Project and standardized criteria were used to identify all cases of BSI and device infection. The incidence of device infection was calculated with person-years of follow-up after device implantation.
Results:
A total of 1524 patients with cardiac devices were included in the cohort. Total person-time of follow-up was 7578 years. The incidence of definite device infection was 1.9 per 1000 device-years (95% confidence interval [CI], 1.1-3.1). The incidence of pocket infection without BSI was 1.37 per 1000 device-years (95% CI, 0.62-3.05), and pocket infection with BSI or device-related endocarditis 1.14 per 1000 device years (95% CI, 0.47-2.74). The cumulative probability of device infection was higher among patients with defibrillators compared with those with pacemakers, P<.001. Twelve (54.6%) of 22 cases of Staphylococcus aureus BSI had definite or possible cardiac device infection vs 3 (12.0%) of 25 cases of bloodstream infection due to gram-negative bacilli (P = .004).
Conclusions:
To our knowledge, this is the first population-based study to describe the incidence of cardiac device infection. Device infection was common during episodes of S aureus BSI. The rate of cardiac device infection was higher in patients with defibrillators than in those with pacemakers.
Related Concept Videos
Endocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Endocarditis IV: Nursing Management
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Endocarditis III: Medical Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
